Age and Gender-Related Changes in Biogenic Amine Metabolites in Cerebrospinal Fluid in Children
- 745 Downloads
Metabolites of cerebrospinal biogenic amines (dopamine and serotonin) are an important tool in clinical research and diagnosis of children with neurotransmitter disorders. In this article we focused on finding relationships between the concentration of biogenic amine metabolites, age, and gender. We analyzed 148 samples from children with drug resistant seizures of unknown etiology and children with mild stable encephalopathy aged 0–18 years. A normal profile of biogenic amines was found in 107 children and those children were enrolled to the study group. The CSF samples were analyzed by HPLC with an electrochemical detector. The concentrations of the dopamine and serotonin metabolites homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA), respectively, were high at birth, gradually decreasing afterward until the 18 years of age. Nevertheless, the HVA/5-HIAA ratio did not vary with age, except in the children below 1 year of age. In the youngest group we observed a strong relationship between the HVA/5-HIAA ratio and age (r = 0.69, p < 0.001). There were no statistical differences in the level of both dopamine and serotonin metabolites between boys and girls, although a trend toward lower HVA and 5-HIAA in the boys was noticeable. Significant inter-gender differences in the level of HVA and 5-HIAA were noted only in the age-group of 1–4 years, with 5-HIAA being higher in the girls than boys (p = 0.004). In conclusion, the study revealed that the concentration of biogenic amine metabolites is age and sex dependent.
KeywordsBiogenic amines Brain metabolism Cerebrospinal fluid Children Gender Neurotransmitters
The study was supported in part by MNiSW grant N406 030 31/0915.
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
- Blau N, Thony B, Cotton RG, Hyland K (2001) Disorders of tetrahydrobiopterin and related biogenic amines. In: Scriver CR, Beaduet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1725–1776Google Scholar
- Blau N, Duran M, Blaskovics ME, Gibson KM (2005) Physician’s guide to the laboratory diagnosis of metabolic diseases, 2nd edn. Springer, HeidelbergGoogle Scholar
- Duarte S, Sanmarti F, Gonzalez V, Perez Duenas B, Ormazabal A, Artuch R, Campistol J, Garcia-Cazorla A (2008) Cerebrospinal fluid pterins and neurotransmitters in early severe epileptic encephalopathies. Brain Dev 30(2):106–111Google Scholar
- Kandel ER, Siegelbaum SA, Schwartz JH (2000) Elementary interactions between neurons: synaptic transmission. In: Kandel ER, Schwartz JH, Jessel TM (eds) Principles of neural science. McGraw-Hill, New York, pp 123–134Google Scholar
- Kusmierska K, Jansen EE, Jakobs C, Szymańska K, Małunowicz E, Meilei D, Thony B, Blau N, Tryfon J, Rokicki D, Pronicka E, Sykut-Cegielska J (2009) Sepiapterin reductase deficiency in a 2-year-old girl with incomplete response to treatment during short-term follow-up. J Inherit Metab Dis 32(Suppl 1):S5–S10CrossRefPubMedGoogle Scholar